These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. [Determination of pyrazinamide susceptibility for Mycobacterium tuberculosis by use of Middlebrook culture media and comparison with results of pyrazinamidase test]. Yamane N; Nakasone I; Yamashita K; Toyoda K; Okazawa Y Rinsho Byori; 1998 May; 46(5):479-85. PubMed ID: 9627500 [TBL] [Abstract][Full Text] [Related]
63. [Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey]. Ozkütük N; Ecemiş T; Sürücüoğlu S Mikrobiyol Bul; 2008 Oct; 42(4):585-90. PubMed ID: 19149079 [TBL] [Abstract][Full Text] [Related]
64. Pyrazinamide resistance in Mycobacterium tuberculosis fails to bite? den Hertog AL; Sengstake S; Anthony RM Pathog Dis; 2015 Aug; 73(6):ftv037. PubMed ID: 25994506 [TBL] [Abstract][Full Text] [Related]
65. Correlation between resistance to pyrazinamide and resistance to other antituberculosis drugs in Mycobacterium tuberculosis strains isolated at a referral hospital. Fonseca Lde S; Marsico AG; Vieira GB; Duarte Rda S; Saad MH; Mello Fde C J Bras Pneumol; 2012; 38(5):630-3. PubMed ID: 23147056 [TBL] [Abstract][Full Text] [Related]
66. Rapid detection of pyrazinamide resistant Mycobacterium tuberculosis by high resolution melting curve analysis. Watcharasamphankul W; Houpt ER; Foongladda S J Med Assoc Thai; 2013 Sep; 96(9):1218-23. PubMed ID: 24163999 [TBL] [Abstract][Full Text] [Related]
67. Pyrazinamide resistance determined by liquid culture at low pH better correlates with genetic mutations in MDR tuberculosis isolates. Pang Y; Wang Z; Zheng H; Song Y; Wang Y; Zhao Y J Microbiol Methods; 2015 Dec; 119():142-4. PubMed ID: 26506283 [TBL] [Abstract][Full Text] [Related]
68. Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis. Lelovic N; Mitachi K; Yang J; Lemieux MR; Ji Y; Kurosu M J Antibiot (Tokyo); 2020 Nov; 73(11):780-789. PubMed ID: 32472054 [TBL] [Abstract][Full Text] [Related]
69. Detection of Willby MJ; Wijkander M; Havumaki J; Johnson K; Werngren J; Hoffner S; Denkinger CM; Posey JE Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084743 [TBL] [Abstract][Full Text] [Related]
70. Microarray-based pncA genotyping of pyrazinamide-resistant strains of Mycobacterium tuberculosis. Denkin S; Volokhov D; Chizhikov V; Zhang Y J Med Microbiol; 2005 Dec; 54(Pt 12):1127-1131. PubMed ID: 16278424 [TBL] [Abstract][Full Text] [Related]
72. Mechanism and resistance for antimycobacterial activity of a fluoroquinophenoxazine compound. Garcia PK; Annamalai T; Wang W; Bell RS; Le D; Martin Pancorbo P; Sikandar S; Seddek A; Yu X; Sun D; Uhlemann AC; Tiwari PB; Leng F; Tse-Dinh YC PLoS One; 2019; 14(2):e0207733. PubMed ID: 30794538 [TBL] [Abstract][Full Text] [Related]
73. Characterization of the MSMEG_2631 gene (mmp) encoding a multidrug and toxic compound extrusion (MATE) family protein in Mycobacterium smegmatis and exploration of its polyspecific nature using biolog phenotype microarray. Mishra MN; Daniels L J Bacteriol; 2013 Apr; 195(7):1610-21. PubMed ID: 23292779 [TBL] [Abstract][Full Text] [Related]
74. Correlation of over-expression of rv1900c with enhanced survival of M. smegmatis under stress conditions: Modulation of cell surface properties. Kumari B; Kaur J Gene; 2021 Jul; 791():145720. PubMed ID: 34019937 [TBL] [Abstract][Full Text] [Related]
75. Role of porins for uptake of antibiotics by Mycobacterium smegmatis. Danilchanka O; Pavlenok M; Niederweis M Antimicrob Agents Chemother; 2008 Sep; 52(9):3127-34. PubMed ID: 18559650 [TBL] [Abstract][Full Text] [Related]
76. Overexpression of a membrane transport system MSMEG_1381 and MSMEG_1382 confers multidrug resistance in Mycobacterium smegmatis. Salini S; Muralikrishnan B; Bhat SG; Ghate SD; Rao RSP; Kumar RA; Kurthkoti K Microb Pathog; 2023 Dec; 185():106384. PubMed ID: 37838146 [TBL] [Abstract][Full Text] [Related]
77. Mycobacterium smegmatis RoxY is a repressor of oxyS and contributes to resistance to oxidative stress and bactericidal ubiquitin-derived peptides. Daugherty A; Powers KM; Standley MS; Kim CS; Purdy GE J Bacteriol; 2011 Dec; 193(24):6824-33. PubMed ID: 21984791 [TBL] [Abstract][Full Text] [Related]
78. Resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones - Authors' reply. Zignol M; Floyd K Lancet Infect Dis; 2017 Jan; 17(1):25. PubMed ID: 27998569 [No Abstract] [Full Text] [Related]
79. Mycobacterium smegmatis MfpC is a GEF that regulates mfpA translationally to alter the fluoroquinolone efficacy. Huang Y; Shen Q; Xu H; Huang L; Xiang S; Li P; Fan L; Xie J Commun Biol; 2024 Aug; 7(1):1035. PubMed ID: 39179666 [TBL] [Abstract][Full Text] [Related]
80. Identification of M. tuberculosis Rv3441c and M. smegmatis MSMEG_1556 and essentiality of M. smegmatis MSMEG_1556. Li S; Kang J; Yu W; Zhou Y; Zhang W; Xin Y; Ma Y PLoS One; 2012; 7(8):e42769. PubMed ID: 22905172 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]